R-(+)-EU-1180-453

CAS No. 2488764-06-1

R-(+)-EU-1180-453( —— )

Catalog No. M36292 CAS No. 2488764-06-1

R-(+)-EU-1180-453 is a novel GluN2C/D selective NMDAR-positive modulator for the study of neurological disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 933 In Stock
10MG 1254 In Stock
25MG 1872 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    R-(+)-EU-1180-453
  • Note
    Research use only, not for human use.
  • Brief Description
    R-(+)-EU-1180-453 is a novel GluN2C/D selective NMDAR-positive modulator for the study of neurological disorders.
  • Description
    R-(+)-EU-1180-453 is a novel GluN2C/D selective NMDAR-positive modulator for the study of neurological disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    NMDAR
  • Recptor
    NMDAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2488764-06-1
  • Formula Weight
    380.41
  • Molecular Formula
    C22H21FN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OC1=CC=C(OC)C=C1)[C@H]2C=3N(CC(=O)N2CC4=CC(F)=CC=C4)C=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • NMDA-IN-1

    NMDA-IN-1 is a potent and NR2B-selective antagonist of NMDA(NMDA Ki of 0.85 nM; NR2B Ca2+ influx IC50 is 9.7 nM).

  • Dextrorphan (tartrat...

    Dextrophan tartrate is a glutamate receptor antagonist potentially for the treatment of stroke.

  • MDL 29951

    MDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H]glycine binding) in vitro and in vivo.